SCHEMBL27202473

SCHEMBL27202473

Nc1ccc(-c2nc3ccc(Cl)cc3[nH]2)cc1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.82
MEN1 O00255 9/20 0.82
KMT2A Q03164 9/20 0.82
MAPT P10636 9/20 0.82
SMN1; SMN2 Q16637 9/20 0.82
HPGD P15428 9/20 0.82
NPC1 O15118 9/20 0.82
KDM4E B2RXH2 8/20 0.82
RAB9A P51151 7/20 0.82
TP53 P04637 7/20 0.82
HSD17B10 Q99714 5/20 0.82
GAA P10253 5/20 0.82
NFKB1 P19838 3/20 0.82
NFKB2 Q00653 2/20 0.82
RELA Q04206 2/20 0.82
APP P05067 1/20 0.82
SNCA P37840 1/20 0.82
MCL1 Q07820 1/20 0.82
GLA P06280 3/20 0.76
GFER P55789 3/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26731643 0.90 MEN1 (1.00) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL8396715 0.90 ALDH1A1 (0.81) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
Hydrochloric Acid SCHEMBL3199369 0.89 MEN1 (0.97) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL5761334 0.87 ALDH1A1 (0.68) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL15443953 0.86 MEN1 (0.87) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL363703 0.86 MEN1 (1.00) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL2251258 0.84 MEN1 (1.00) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL7394696 0.84 MEN1 (0.71) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL4185889 0.84 KDM4E (0.94) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL12351750 0.83 MEN1 (1.00) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240131007-A1 METHODS AND COMPOSITIONS FOR PICORNAVIRUS ANTI-VIRAL AGENTS UNIVERSITY OF CONNECTICUT 2024-04-25 US disclosed
CN-111875545-A Directional synthesis method and application of 6-substituted benzimidazole derivative 安阳师范学院 2020-11-03 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240131007-A1 METHODS AND COMPOSITIONS FOR PICORNAVIRUS ANTI-VIRAL AGENTS RNASEH1, HNRNPA2B1, HNRNPA1 ALDH1A1 3057/4885MEN1 3483/4885KMT2A 3935/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.